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Abstract: 37 
 38 
The molecular and cellular processes driving the formation of secondary lymphoid tissues have 39 
been extensively studied using a combination of mouse knockouts, lineage specific reporter 40 
mice, gene expression analysis, immunohistochemistry and flow cytometry.  However, the 41 
mechanisms driving the formation and function of tertiary lymphoid tissue (TLT) experimental 42 
techniques have proven to be more enigmatic and controversial due to differences between 43 
experimental models and human disease pathology.  Systems-based approaches including data-44 
driven biological network analysis (Gene Interaction Network, Metabolic Pathway Network, 45 
Cell-Cell signalling & cascade networks) and mechanistic modelling afford a novel perspective 46 
from which to understand TLT formation and identify mechanisms that may lead to the 47 
resolution of tissue pathology.  In this perspective, we make the case for applying model-driven 48 
experimentation using two case studies which combined simulations with experiments to 49 
identify mechanisms driving lymphoid tissue formation and function, and then discuss 50 
potential applications of this experimental paradigm to identify novel therapeutic targets for 51 
TLT pathology. 52 
 53 
 54 
 55 
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Formation and function of secondary and tertiary immune microenvironments 56 
 57 
Lymphoid tissues are responsible for the orchestration of functional immune responses. This 58 
is achieved through the development and maintenance of niches that support the retention, 59 
activation and proliferation of adaptive immune cells in response to antigenic stimulation.  60 
Adult lymphoid tissue architecture is organised by an underlying network of stromal cells that 61 
produce extracellular matrix (e.g. collagens) and provide survival (e.g. BAFF, IL-7), migratory 62 
(CCL19/21, CXCL13) and immune activation (the storage and presentation of immune 63 
complexes by follicular dendritic cells) signals (Junt et al, 2008).  Distinct stromal subsets with 64 
unique secretion profiles (chemokines, other cytokines, survival factors) develop in response 65 
to signalling from lymphocytes with a key role for TNF superfamily receptors; this stromal-66 
lymphocyte cross-talk ensures the correct cell type is stimulated (or regulated) at the right time 67 
and place.  Sustained cross-talk between mesenchymal stroma and lymphocyte subsets is a core 68 
feature of lymphoid tissue formation and maintenance, and occurs irrespective of the tissue 69 
type or anatomical location. 70 
 71 
Formation of lymphoid tissues can occur by different cellular and molecular mechanisms.  72 
During foetal development secondary lymphoid tissues form in a process dependent on the 73 
RAR-related orphan receptor gamma, RORγ transcription factor expressing lymphoid tissue 74 
inducer cells (LTi) responding to localised chemotactic gradients leading to formation of lymph 75 
nodes (LN) and Peyer’s patches (PP) in a lymphotoxin β (LTβ) dependent process (Pavert & 76 
Mebius, 2010). Localised mesenchyme, lymphoid tissue organiser (LTo) cells differentiate into 77 
adult marginal reticular cells (MRCs), fibroblastic reticular cells (FRCs) and follicular 78 
dendritic cells (FDCs) (Jarjour et al., 2014).  Likewise, in the adult, innate lymphoid cells type 79 
3 (ILC3s), the adult equivalent of LTi cells, have a key role in regulating crypto-patches that 80 
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can mature into isolated lymphoid follicles (Mowat and Agace, 2014). These specialised 81 
lymphoid structures contain predominantly B cells and often contain germinal centre (GC) 82 
reactions. 83 
 84 
In humans, tertiary lymphoid tissues (TLT) are found in inflammatory immune responses 85 
associated with chronic pathology from hip joint replacements, keloids, tissues in autoimmune 86 
disease (e.g. the salivary gland in Sjogren’s syndrome, multiple sclerosis and rheumatoid 87 
arthritis) to solid tumours and follicular lymphomas in the bone marrow (Mittal et al., 2013; 88 
Bombardieri et al., 2012; Bagabir et al., 2012; Dieu-Nosjean et al., 2016; Guilloton et al., 89 
2012).  Although the role of specific cell types has been controversial, there is an emerging 90 
paradigm of a multi-step process where localised inflammation induces stromal cell activation 91 
in a lymphocyte independent process, leading to localised microenvironments permissive for 92 
T and B cells entry (De Silva & Klein, 2015). These lymphocytes have the potential to drive 93 
the formation of organised tertiary tissue in an autocrine dependent process.  This process 94 
closely resembles the capacity of naïve B cells to drive B cell follicle formation in secondary 95 
lymphoid tissues in a TNFα and LTβ dependent process, and the capacity of activated B cells 96 
to generate the germinal center (GC), a transient microenvironment that drives high affinity 97 
immune responses in a self-regulating autocrine dependent process.  In both secondary immune 98 
tissues (LN, PP and spleen) and tertiary lymphoid tissues including ILFs and TLT, activated B 99 
cells prime the formation of the GC reaction.  This specialised microenvironment contains both 100 
activated and proliferating B cells and different stromal compartments of CXCL12 secreting 101 
stroma (dark zone) and CXCL13 secreting FDCs (light zone).  This facilitates the cyclic 102 
selection and expansion of antigen specific B cells (Zhang et al., 2016). 103 
 104 
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Non-lymphoid inflammatory immune structures, granulomas, can form in the liver, intestine, 105 
adipose tissue (crown-like structures) and lung induced by chronic infection/inflammation 106 
associated with tuberculosis, leishmaniasis, schistosomiasis, cell death and Crohn’s disease 107 
(Sandor et al., 2003; Beattie and Kaye, 2016; Bolus et al., 2015). The formation of these highly 108 
dynamic microenvironments superficially resemble TLT, however their formation and 109 
organisation is driven by activated macrophages rather than by the mesenchymal-lymphocyte 110 
cross-talk observed in lymphoid tissues thus do not exhibit lymphocyte compartmentalisation. 111 
Granuloma structures are very heterogeneous in presentation within individual patients in a 112 
continuum between early macrophage centric granulomas, self-resolving granulomas to 113 
fibroblastic structures, these often being fibrotic rather than taking on a supportive stromal 114 
network phenotype.  The triggers that drive granuloma formation instead of TLT formation 115 
appear not to be due to differences in the different chemotactic cues delivered by activated 116 
macrophages compared to those delivered by activated stromal fibroblasts leading to a very 117 
different cellular make up to the inflammatory foci of leukocytes (primarily myelo-monocytic 118 
(granuloma) vs. lymphocytic (TLT)). 119 
 120 
Current approaches to studying lymphoid tissue formation: Limits, challenges ad new 121 
approaches. 122 
 123 
Experimental studies, principally performed in gene knockout, lineage specific fluorescent 124 
protein and Cre reporter mouse lines have contributed significant insights into the roles of 125 
multiple different cell types and molecules in lymphoid tissue formation and function. This has 126 
been further validated using histology and flow cytometry analysis on human secondary 127 
lymphoid tissues.  However, in contrast to secondary lymphoid tissues there are some distinct 128 
differences in human tissue pathologies to those found in mice including the cellular 129 
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composition of TLTs, granulomas and other inflammatory tissues. This arises in part from 130 
genetic and physiological differences between human and mice including the timing and 131 
duration of the immune response (chronic vs acute inflammation), the inflammatory triggers 132 
(infection, autoimmunity and cancer) and transcriptional differences in immune cells in the 133 
different species.  In general, mouse models of immune mediated inflammatory disease are 134 
acute and fail to replicate the chronic human disease characterised by disease flairs followed 135 
by remission, limiting their translational capacity to human disease.  Infection and tumour 136 
models in mice either rapidly resolve (too quickly for chronic pathology to establish) or lead 137 
to the mouse having to by euthanized for health and welfare prior to tertiary lymphoid 138 
pathology occurring.  In comparison, humans may live the rest of their life with the disease 139 
pathology, particularly in the context of treatment with biologics and small molecules, thus 140 
pathology has the opportunity to evolve from localised inflammation to fibrotic tissue failure, 141 
systemic inflammation and autoimmunity working together to prevent disease resolution.  142 
Increasingly human 3-dimensional tissue culture models containing both stroma and 143 
lymphocytes have become increasingly common and useful in understanding underlying 144 
molecule mechanisms of TLT formation.  However, it is not currently possible to represent the 145 
full complexity of chronic human pathology in vitro. 146 
 147 
Experimental systems (in vivo and in vitro) to date have proven limited in their ability to explain 148 
chronic clinical pathology and resolve established Sjogren’s pathology, although TNF has an 149 
important role in FDC differentiation and B cell organisation, anti-TNF fails to induce 150 
resolution disease (Sankar, 2004). To better understand the form and function of TLTs, current 151 
knowledge of stromal regulation through molecular signals and immune cell behaviour within 152 
lymphoid tissue must be consolidated and considered in a quantitative, systems-based 153 
approach. The development of systems-level stochastic computational models can bring 154 
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together a broad understanding across spatiotemporal scales of how genetic and molecular 155 
factors relate to cellular and tissue level form and function, and give rise to the complex, 156 
functional architectures observed in secondary lymphoid organs and disease specific TLT. 157 
These models permit in silico experimentation providing a unique platform driving further 158 
experimentation and assessing novel mechanistic targets and intervention strategies where in 159 
vivo observed heterogeneity can be replicated. 160 
 161 
Alan Turing (of code breaking fame) in seminal early work in mathematical biology (Turing, 162 
1952) noted that gastrulation, arose from symmetry breaking, this leads to fundamental insights 163 
and principles that drive modern mathematical and computational biology: the notion that 164 
chaotic, non-linear behaviour of individual biological processes, including the self-165 
organisation of complex biological structures (e.g. TLT), can result in emergent properties that 166 
cannot be understood from consideration of each individual component in isolation. The 167 
development of models that capture the essential, emergent behaviour of specific biological 168 
processes, with extraneous components excluded, enables understanding of how complex 169 
molecular and cellular interactions govern complex, emergent biological processes and can 170 
therefore lead to new insights and quantitative predictions (Callard and Yates, 2005).  Emergent 171 
properties in a TLT model would include stromal networks, lymphocyte organisation, 172 
migration and interactions with antigen presenting cells, and localised cytokine/chemokine 173 
production. 174 
 175 
Application of model-driven experimentation to understand mechanisms of lymphoid 176 
tissue development and function. 177 
 178 
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Advances in computing resources and computational modelling technology has provided the 179 
capacity to generate complex in silico models of lymphoid tissues that incorporate space, time 180 
and cellular heterogeneity found in immune tissues including TLT.  Applying in silico 181 
approaches to understand secondary lymphoid tissue formation and function requires the 182 
integration of experimental data across cellular, molecular and tissue levels of organisation.  183 
Ensuring that the biological processes are appropriately described requires a fine balance 184 
between model abstraction and interpretation (quantitative and qualitative) of experimental 185 
data.  A number of different modelling approaches may be utilised (summarised in Table 1), 186 
increasingly, integration of different mathematical/computational techniques into a hybrid 187 
model is a common strategy to address the limitations of using each technique in isolation. This 188 
approach also facilitates the consolidation of data across different levels of organisation 189 
(molecular, cellular, tissue and patient) into a single multiscale model. For example, an agent-190 
based model can capture an individual cell, which in turn incorporates a differential equation-191 
based model capturing a ‘lower-level’ aspect of that individual's behaviour, such as surface 192 
expression of a receptor. Adopting an in silico approach provides a platform that can provide 193 
insights and generate predictions that can be verified in vivo: verification that can lead to 194 
increased biological understanding and incrementally improved in silico models for further 195 
experimentation.  This iterative approach of combining in vivo, in vitro and in silico approaches 196 
has been termed ‘model-driven experimentation’ (MDE)(Ganesan & Levchenko, 2012). 197 
 198 
Case Study 1: Insights from MDE to secondary lymphoid tissue formation: 199 
 200 
Peyer’s patches (PP) are specialised secondary lymphoid tissues of the intestine that develop 201 
during a fixed window in foetal development and have an essential role in maintaining 202 
intestinal immunity.  PP form stochastically along the mid-gut, with mice developing 8-12 203 
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patches, however, as the absence of or reduction in the number of PPs is observed in several 204 
different gene knockouts, the molecular process which triggers patch formation was unclear 205 
(Veiga-Fernandes et al., 2007). Using an MDE based approach had the potential to provide 206 
new insight into how different signalling pathways (RET, chemokine receptors, cytokine 207 
receptors, TNF superfamily, adhesion molecules) might integrate to induce PP development in 208 
silico and to subsequently design key experiments to test hypotheses in vivo.  PPSim is an agent 209 
based Peyer’s patch simulator that captures key processes during the 72-hour period of tissue 210 
development in prenatal mice and replicates (statistically similar) emergent cell behaviours 211 
found in vivo, specifically Populations of haematopoietic cells, known as Lymphoid Tissue 212 
Initiator (LTin) and Lymphoid Tissue Inducer (LTi) cells, migrate into the developing gut, with 213 
data from laboratory observations suggesting these cells follow a random motion. Both cell 214 
populations express receptors for the adhesion molecule VCAM-1, expressed by stromal 215 
Lymphoid Tissue Organizer (LTo) cells residing in the gut wall. (Alden et al., 2012; Patel et 216 
al., 2012). In this computational model LTi and LTin are captured as individual entities that 217 
migrate into the developing mid-gut serosa and undergo a random walk, interacting with their 218 
localised simulated environment through signalling pathways including GDRFs/Ret signalling 219 
pathways, adhesion molecules and chemokine receptors, as is observed in vivo.  On ensuring 220 
PPsim adequately represented individual cell responses, statistical analysis techniques, 221 
specifically sensitivity analyses, were used to explore mechanisms driving prenatal lymphoid 222 
organ formation (Alden et al., 2013; Butler et al., 2014). This exploration of the simulated 223 
biological pathways revealed which pathways had significant impacts on simulated cell 224 
behaviour at different time points during PP development. By examining correlations in the 225 
level of activity of simulated pathways and cell behaviour, the hypothesis was derived that 226 
contact between LTin and LTo cells that leads to the localised upregulation of VCAM-1 on 227 
stromal cells was the key triggering event that determined the site of PP formation on the mid-228 
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gut (Patel et al., 2012). Utilising this prediction, an in vitro assay imaging foetal mid-gut 229 
explants incubated in the presence or absence of anti-VCAM-1 antibodies was developed. 230 
Using this assay, it was verified that early upregulation of VCAM-1 was the triggering event 231 
that was essential for the initiation of LTi & LTin cell clustering.  The model simulation results, 232 
supported by replicated experimentation and safety-critical systems-based fitness-for-purpose 233 
argumentation that details the knowledge integration in model composition, provide evidence 234 
that the simulation was fit for the purpose of aiding exploration of this specific research 235 
question: understanding the triggering of lymphoid tissue development which was not possible 236 
by conventional genetic approaches (Alden et al., 2015a; Alden et al., 2015b). 237 
 238 
Case Study 2: Applying MDE to understand germinal centre dynamics and function 239 
 240 
The GC reaction is a transient microenvironment in which affinity maturation occurs in 241 
response to immunisation and infection bearing key similarities to TLT in its evolution in the 242 
role of lymphocytes in inducing highly organised stromal networks, the essential role of TNF 243 
superfamily members in regulating its induction and the induction of chemokine gradients (De 244 
Silva and Klein, 2015; Victora and Mesin, 2014).  However, in comparison to TLT, the GC is 245 
a self-resolving tertiary lymphoid microenvironment. Recent technological advances, 246 
particularly the advent of intravital multiphoton imaging including photo-activated fluorescent 247 
proteins has led to the unprecedented availability of data on the dynamics B-cell migration and 248 
selection (Allen et al., 2007; Schwickert et al., 2007; Shulman et al., 2013, 2014).  However, 249 
imaging datasets provide a narrow window of insight into a process that occurs over a timescale 250 
of days and weeks. Furthermore, as imaging techniques are optimised for a given time and 251 
length scale, they are limited in their ability to link molecular, cellular and tissue level 252 
processes.  This has made the interpretation of imaging datasets in the context of the wider 253 
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literature challenging. To address this issue modelling approaches have been used to test the 254 
validity of different hypotheses for mechanisms controlling B-cell migration and selection 255 
within the GC (Chan et al., 2013; Figge et al., 2008; Meyer-Hermann, 2006; Meyer-Hermann 256 
et al., 2012). 257 
With respect to the germinal centre, model-derived insights have proved useful not only in the 258 
analysis of existing datasets but also as a driver for further experimentation. Specifically, an 259 
MDE approach to examine the effects of antibody-feedback on the process of affinity 260 
maturation (Zhang et al., 2013).  Analysis of an in silico GC reaction yielded the prediction 261 
that GC B-cells, which require antigen on FDCs for positive selection, were competing for 262 
antigen by early low-affinity antibodies. Only higher affinity B-cells were able to outcompete 263 
for antigen to receive the necessary survival signals. To experimentally validate this prediction, 264 
the authors manipulated the GC response with monoclonal antibodies of defined affinities and 265 
were able to confirm that antibody feedback provides a dynamic selection threshold to 266 
maximise Ig affinities (Zhang et al., 2013). A similar approach was employed to investigate 267 
the role of Toll-like receptor 4 (TLR4) on the GC where an iterative cycle of in silico and in 268 
vivo experimentation dissected the importance of TLR4 signalling on the maturation of 269 
Follicular Dendritic Cells, key regulators of B-cell selection in the light zone of the GC (Garin 270 
et al., 2010).  Both of these MDE examples highlight the use of in silico experimentation as a 271 
means of refining the use of experimental animals and available resources through the 272 
identification of key time-points and conditions to test in vivo.  These case studies together 273 
provide example of how theoretical models can consolidate data from different sources as a 274 
platform for the development novel hypotheses and a driver for further experimentation. 275 
 276 
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Perspective on MDE as applied to tertiary lymphoid tissue formation, function and 277 
therapeutic resolution. 278 
 279 
When computational modelling is combined with the knowledge that can be derived from next 280 
generation imaging, multi-dimensional cytometry and gene expression analysis of human TLT 281 
pathology, MDE has the potential to provide novel insights to key questions on molecular and 282 
cellular mechanisms involved in TLT formation, maintenance and function similar to its 283 
capacity to impact on our understanding of lymphoid stromal network and granuloma dynamics 284 
(Table 2)(Kislitsyn, A et al., 2015; Novkovic M et al., 2016; Warsinke et al., 2016; Marino et 285 
al., 2016).  One of the key advantages of applying multi-scale modelling is it permits capture 286 
of a wide range of different phenomena that occur on different orders of magnitude in terms of 287 
time and length scales that are critical in the stochastic processes involved in TLT induction.  288 
These include different cell types, states and interactions, inflammatory molecules, 289 
extracellular matrix, adhesion molecules and chemotactic signals all in the context of an 290 
evolving tissue microenvironment.  Developing in silico models permits temporal inhibition of 291 
different signalling pathways and cellular depletions during different stages of TLT pathology 292 
using statistical tools (Figure 1).  This permits identification of key pathways that could be 293 
targeted to induce resolution of pre-existing TLT rather than inhibiting its formation as has 294 
been used to make in silico predictions for the treatment of tuberculosis (Pienarr et al., 2015).  295 
A large number of novel antibody therapies, biologics and small molecular inhibitors have been 296 
developed to target immune function for the treatment of immune mediated inflammatory 297 
diseases.  These therapies are unlikely to show maximal efficacy against existing tissue 298 
pathology when used as mono-therapies, rather it is more likely that use of therapeutic 299 
combinations that is most likely to show clinical efficacy.   The clinical challenge is that there 300 
are already over 20,000 possible different combinations using existing therapeutics that would 301 
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need to be trialled to find optimal targeting strategy to resolve TLT pathology.  Thus MDE 302 
based approaches provide a rational approach to identify novel combination therapeutic 303 
regimes that have a best potential in clinical trials. 304 
 305 
Although the adoption of MDE has only recently started to impact on immunology research, it 306 
is starting to have a very significant impact on other areas of biology.  We propose that the 307 
increased accessibility of computational models, high-performance computing resources, the 308 
increased familiarity and understanding of simulations as tools to understand immune function 309 
and the capacity to apply in silico approaches to identify potential therapeutic approaches and 310 
disease biomarkers will accelerate the application of MDE as a methodology understand and 311 
target disease resolution.   312 
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Table 1: Mathematical and Computational Techniques for Modelling Immune Processes 507 
Technique Description Comments 
ODE 
Ordinary Differential Equations: Describe the rate of 
change with respect to one other variable (e.g. 
population change over time, t). 
Commonly used technique 
that can be used to 
quantify changes in 
population size over time. 
PDE 
Partial Differential Equations: Describe rate of change 
of a function of more than one variable with respect to 
one of those variables (e.g. motion through space x,y,z 
as a function of time t).  
Often used to describe 
changes occurring over 
both time and multiple 
spatial dimensions. 
Monte Carlo 
Statistical random sampling method where outcomes 
are determined at random from input probability 
distribution functions. 
Stochastic technique to 
model deterministic 
processes, very frequently 
integrated within ABM, 
CPM and other stochastic 
modelling approaches. 
Petri Nets 
Graph based model describing network of events or 
‘transitions’ that occur depending on given conditions 
or ‘places’; a stochastic methodology. 
Computationally efficient, 
can be effectively defined 
using SBML2. Capturing 
explicit spatial 
representation can be 
difficult. 
ABMs 
Agent Based Models are composed of individual 
entities specified as agents which exist independently 
in a well-defined state: a set of attributes at a specific 
point in (e.g.) time and space, with state-transitions 
governed by a rule-set, often described in terms of 
Finite State Machines and other diagrammatic 
constructs using the UML (Unified Modelling 
Language). 
There are a number of 
methodologies to generate 
ABMs.  There are tools 
with user interfaces for 
constructing simpler 
lattice-based ABMS, or 
‘unconstrained’ models 
manually coded as 
software in languages such 
as Java and C++.  
(Extended) 
Cellular Potts 
Modelling 
A lattice based modelling technique for simulating the 
collective behaviour of cells. A cell is defined as a set 
of pixels within a lattice (sharing a ‘spin state’), and is 
updated pixel-by-pixel according to a mathematical 
function which incorporates cell volume, and 
surface/adhesion energies. 
Similar to an ABM, but 
relies on effective energy 
functions (the 
Hamiltonian) to describe 
cellular adhesion, 
signalling, motility and 
other physical phenomena. 
Hybridised 
Models 
Bringing together a range of different techniques 
generally within the context of an ABM or CPM, 
incorporating differential equations and a variety of 
other mathematical and computational techniques to 
effectively capture phenomena occurring over 
different spatiotemporal scales (e.g. intracellular 
activity) 
Can take advantage of 
different modelling 
techniques, particularly 
applicable where there are 
multiple processes 
occurring in different 
scales of time and space. 
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Table 2: Key questions on TLT formation and maintenance that can be address in hybridised 508 
TLT models 509 
Formation 
 
What are the minimum cellular requirements to initiate TLT formation? Is this driven by 
different types of stroma, lymphocytes, dendritic cells or tissue resident macrophage? 
 
 
What is the relative importance of inflammation and antigen in TLT induction?  Is 
autoantigen required for induction or just an outcome of the pathology? 
 
 
What is the role of different cytokines and chemotactic signals on TLT formation? 
 
Maintenance 
 
What is the relative role of inflammatory cytokines, lymphocyte – stromal cross talk, immune 
cell entry, cell death, antigenic stimulation on TLT maintenance?  
  
 
What are the key signalling pathways required to maintain TLT once it has formed? Can 
these pathways be targeted to induce TLT resolution? 
 
 
Can TLT self-resolve in humans? If so what is the balance between new TLT induction and 
resolution of existing structures? 
 
 510 
  511 
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 512 
 513 
 514 
Figure 1:  Application of Model-driven Experimentation to develop new mechanistic 515 
understanding of TLT formation and maintenance permitting identification of novel 516 
therapeutic approaches to resolve localised TLT pathology. 517 
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